Skip to content

Micronutrient and Additive Modifications May Optimize Diet To Health

Micronutrient and Additive Modifications May Optimize Diet To Health

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05743374
Acronym
Mammoth
Enrollment
70
Registered
2023-02-24
Start date
2024-04-02
Completion date
2029-12-31
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet Habit, Microbial Colonization, Ulcerative Colitis

Keywords

Ulcerative colitis, Diet, Microbiota, Emulsifying agent

Brief summary

This is a prospective clinical intervention trial where patients with moderately active ulcerative colitis are randomized to either normal healthy diet or a diet with elimination of emulsifying agents within the E 400-group with special respect to carragenan, CMC and polysorbates. At study start and end after one month their diet, clinical characteristics and microbiota will be analysed. The hypotheses are that their disease activity measured with calprotectin and their microbiota will improve after intervention.

Detailed description

Patients with ulcerative colitis attending the out-patient clinic at Skåne university hospital with calprotectin 100-600 will be invited to participate in this diet intervention study. They will be divided into two arms with 35 patients in each, normal diet or E-400 elimination. The diet will be recorded at study start and end with a food diary for four days and a food frequency questionnaire regarding E-400 intake. The patients clinical characteristics (demographics) and disease activity (diarrhoea frequency, blood in stools, abdominal pain, CRP and calprotectin) will be recorded and microbiota collectted. The hypotheses are that the activity measured with clinical characteristics and calprotectin as well as their microboita measured with dysbiosis index and total genom with NGS will improve significantly.

Interventions

OTHERNormal diet

These patients will be given advice about a normal healthy diet.

DIETARY_SUPPLEMENTE400 elimination

Patients in the intervention group will be given advice how to eliminate E440 additives with regard to carragenan, CMC and polysorbates.

Sponsors

Region Skane
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

Although the patients know that they will be given dietary advice they will not know what type of intervention the other group will be offered. Since dietary advice must be given by the investigators the study cannot be blinded to them.

Intervention model description

Prospective randomized intervention study with elimination of putatively harmful substances in the diet

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ulcerative colitis, * Moderately active * Stable medication

Exclusion criteria

* Severe disease * Recent surgery * Proctitis * Pregancy * Treatment with antibiotics * Difficulties in understanding the information about the study * Multimorbidity that makes it impossible to participate

Design outcomes

Primary

MeasureTime frameDescription
CalprotectinOne monthA protein in faeces that increases when there is a flare of the colitis
Microbiota diversityOne monthThe diversity of the GI microbiota reflects disease severity

Countries

Sweden

Contacts

Primary ContactKlas Sjöberg, Prof
klas.sjoberg@med.lu.se+46702372580
Backup ContactSanna Davidson, MD
sanna.davidson@med.lu.se+4640332185

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026